Aarti Pharmalabs Achieves 52-Week High Amid Positive Market Trends and Strong Performance Metrics

May 21 2025 12:35 PM IST
share
Share Via
Aarti Pharmalabs has achieved a new 52-week high in its stock price, reflecting strong performance in the pharmaceutical sector. The company reported impressive metrics, including significant annual returns and robust quarterly sales. Its financial health is solid, highlighted by a low Debt to EBITDA ratio, indicating effective debt management.
Aarti Pharmalabs has made headlines today as its stock price reached a new 52-week high of Rs. 867, marking a significant milestone for the midcap pharmaceutical and biotechnology company. This achievement comes amid a broader positive trend in the market, with the BSE Mid Cap index gaining 0.46% and the Sensex trading higher.

The stock has outperformed its sector by 1.2%, showcasing its strong market position. Aarti Pharmalabs has demonstrated impressive performance metrics, including a remarkable return of 49.72% over the past year, significantly outpacing the Sensex's 10.14% return. The company's financial health is underscored by a low Debt to EBITDA ratio of 0.63 times, indicating a strong ability to service its debt.

Recent quarterly results have also been promising, with net sales reaching Rs. 563.78 crore and a return on capital employed (ROCE) of 16.13%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, reflecting a bullish technical trend. Despite some concerns regarding long-term growth and institutional investor participation, Aarti Pharmalabs continues to demonstrate robust performance indicators in the competitive pharmaceutical landscape.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News